Connect Biopharma (CNTB) Stock Chart & Stock Price History $1.92 -0.13 (-6.34%) Closing price 08/18/2025 04:00 PM EasternExtended Trading$2.01 +0.09 (+4.69%) As of 08/18/2025 06:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Connect Biopharma Stock Price Performance The Connect Biopharma (CNTB) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 68.42%, with a year-to-date return of 39.13%. In the past month, the stock has increased 11.63%, reflecting recent market activity. As of the latest close, Connect Biopharma traded at $1.92 with a market cap of $106.98 million and volume of 193,176 shares. Receive CNTB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Connect Biopharma and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-10.70%1 Month Performance+11.63%3 Month Performance+144.62%Year-To-Date Performance+39.13%1 Year Performance+68.42% CNTB Stock Chart for Tuesday, August, 19, 2025 CNTB Chart by TradingView Connect Biopharma Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/18/2025$2.05$1.92-6.34%$2.08$1.77193,176 shs$106.98 million08/15/2025$2.15$2.05-4.65%$2.14$1.88152,118 shs$113.90 million08/14/2025$2.36$2.15-8.90%$2.36$2.05144,902 shs$119.46 million08/13/2025$2.27$2.36+3.96%$2.46$2.12255,118 shs$131.12 million08/12/2025$2.05$2.27+10.73%$2.43$2.08194,027 shs$126.12 million08/11/2025$2.07$2.05-0.97%$2.27$2.0390,664 shs$113.90 million08/08/2025$2.07$2.07$2.19$2.0169,893 shs$115.01 million08/07/2025$2.13$2.07-2.82%$2.26$1.9280,804 shs$115.01 million08/06/2025$2.20$2.13-3.18%$2.31$2.05137,940 shs$118.34 million08/05/2025$2.04$2.20+7.84%$2.20$1.9480,045 shs$122.23 million Get the Latest News and Ratings for CNTB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Connect Biopharma and its competitors with MarketBeat's FREE daily newsletter. 08/04/2025$2.00$2.04+2.00%$2.11$1.87129,318 shs$113.34 million08/01/2025$2.02$2.00-0.99%$2.19$1.83240,596 shs$111.12 million07/31/2025$2.10$2.02-3.81%$2.13$1.94150,594 shs$112.23 million07/30/2025$1.75$2.10+20.00%$2.11$1.73279,121 shs$116.68 million07/29/2025$2.08$1.75-15.87%$2.12$1.70271,720 shs$97.23 million07/28/2025$2.22$2.08-6.31%$2.28$1.99183,939 shs$115.57 million07/25/2025$2.35$2.22-5.53%$2.45$2.17122,465 shs$123.34 million07/24/2025$2.27$2.35+3.52%$2.35$2.13142,983 shs$130.57 million07/23/2025$2.38$2.27-4.62%$2.43$1.79396,155 shs$126.12 million07/22/2025$2.00$2.38+19.00%$2.86$2.08837,123 shs$132.23 million07/21/2025$1.72$2.00+16.28%$2.20$1.72363,246 shs$111.12 million07/18/2025$1.86$1.72-7.53%$1.89$1.67262,179 shs$95.56 million Related Companies ITOS Stock Chart KOD Stock Chart KMDA Stock Chart ERAS Stock Chart CGEM Stock Chart CMPS Stock Chart PRTA Stock Chart TECX Stock Chart PRTC Stock Chart CYRX Stock Chart Receive CNTB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Connect Biopharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CNTB) was last updated on 8/19/2025 by MarketBeat.com Staff From Our PartnersWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredBut this $20 American company could control the secretThe "Impossible" Chip That Runs on Pure Light Google's quantum computer shocked the world... but China DEMO...The Oxford Club | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Connect Biopharma Holdings Limited Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Connect Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access